HR 8667 United States House · 119th Congress

MISSION Rx Act

The MISSION Rx Act ensures that military beneficiaries and veterans pay no more for specific negotiated drugs than Medicare Part D beneficiaries do. It achieves this by capping the out-of-pocket costs for TRICARE-covered servicemembers and copayments for veterans at the same levels established under the federal drug price negotiation program. Additionally, the bill requires federal agencies to limit the maximum prices they agree to pay pharmaceutical manufacturers for these same negotiated drugs. These changes apply to existing contracts and new agreements involving drugs selected for federal price negotiation.
Bill status in committee 1 of 4 stages cleared
Introduction
May 2026
Committee Review
Floor Vote
President
Introduced May 7, 2026 Last action May 7, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
1
May 7, 2026
Committee
Referred to the Committee on Veterans' Affairs, and in addition to the Committee on Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
lower
May 7, 2026
Introduced
Introduced in House
lower
1 primary · 15 co-sponsors

Sponsors